Zobrazeno 1 - 10
of 26
pro vyhledávání: '"N. Kärki"'
Publikováno v:
Acta Medica Scandinavica. 171:183-186
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::35d878ee94949c14614fa57fc6df337c
https://doi.org/10.1111/j.0954-6820.1962.tb04179.x
https://doi.org/10.1111/j.0954-6820.1962.tb04179.x
Publikováno v:
Acta Anaesthesiologica Scandinavica. 21:50-54
Urinary excretion of catecholamines was determined separately during the first stage of labour and during the period from the beginning of the second stage until 1/2 h after delivery in 16 healthy mothers, whose labours were induced at term. Seven mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::222ec5c39c9a80b0a5539c2cef8e8840
https://doi.org/10.1111/j.1399-6576.1977.tb01193.x
https://doi.org/10.1111/j.1399-6576.1977.tb01193.x
Publikováno v:
European Journal of Clinical Pharmacology. 15:51-55
Plasma ergotamine levels were measured in 33 volunteers (subgroups 11, 12 and 10) after a single dose of ergotamine administered by various routes. Ergotamine tartrate was given in doses normally used in the treatment of acute migraine--2.0 mg orally
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48aa98728f80ed54a7a67261b5173f79
https://doi.org/10.1007/bf00563557
https://doi.org/10.1007/bf00563557
Publikováno v:
Upsala journal of medical sciences. Supplement. 31
There seems to be great individual differences in the bioavailability of ergotamine in continuous use. The great tolerance to ergotamine in some patients using the drug on a daily basis, even in high doses, may be due to the low-bioavailability of er
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::337a8dcc0af42bf99c423bd2c07bb4f1
https://pubmed.ncbi.nlm.nih.gov/6935854
https://pubmed.ncbi.nlm.nih.gov/6935854
Publikováno v:
European journal of clinical pharmacology. 16(5)
Plasma ergotamine concentrations were determined by radioimmunoassay in 10 healthy subjects after a 2 mg oral dose of ergotamine, administered at 24 h intervals on three consecutive days. After the first dose the mean peak plasma level of 0.35±0.05
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::915e6b4450956afb4beb635b62ca1219
https://pubmed.ncbi.nlm.nih.gov/520404
https://pubmed.ncbi.nlm.nih.gov/520404
Autor:
N, Kärki
Publikováno v:
Sotilaslaaketieteellinen aikakauslehti. 40(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::44f48b2175043bea457f6058b70f5d7e
https://pubmed.ncbi.nlm.nih.gov/5866793
https://pubmed.ncbi.nlm.nih.gov/5866793
Autor:
L. Kalliomäki, N. Kärki
Publikováno v:
Scandinavian Journal of Clinical and Laboratory Investigation. 6:263-264
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d45d4f6dbeb7c098618e857cbcfaea78
https://doi.org/10.3109/00365515409136367
https://doi.org/10.3109/00365515409136367
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.